Cytonex

CytoNex is a South Korean biotechnology company specializing in the isolation and analysis of exosomes and extracellular vesicles (EVs) for diagnostic and therapeutic applications. The company's proprietary platform, the Exosome Capture and Analysis System (ExoCAS), utilizes microfluidic technology to isolate high-purity exosomes from liquid biopsy samples such as blood or urine. This approach offers a significant improvement over traditional methods like ultracentrifugation, enabling faster and more accurate biomarker detection for precision medicine. CytoNex is currently advancing a pipeline of diagnostic kits for various cancers, including lung, breast, and prostate cancer, which are designed to facilitate early detection and treatment monitoring. In addition to diagnostics, the company is exploring the development of exosome-based drug delivery systems for targeted oncology therapies. CytoNex collaborates with leading academic and clinical institutions to validate its technology and integrate it into clinical workflows.